Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts Evofem Biosciences Inc (EVFM) at Overweight
-
Ocugen to Present at Two Upcoming Investor Conferences
-
Chimerix to Present at Cantor Fitzgerald Global Healthcare Conference
-
CTI BioPharma to Present at the Cantor Fitzgerald Global Healthcare Conference Wednesday, Oct. 3
-
Anavex Life Sciences to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Fennec to Present at Cantor Fitzgerald Global Healthcare Conference on October 1, 2018 in New York City
-
Silence Therapeutics to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Silence Therapeutics to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Aduro Biotech to Present at Two Investor Conferences in October
-
BioCryst Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Corvus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Iterum to Present at Cantor Fitzgerald Global Healthcare Conference
-
Exelixis to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018
-
Iterum to Present at Cantor Fitzgerald Global Healthcare Conference
-
AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October
-
Otonomy to Present at Cantor Fitzgerald Global Healthcare Conference
-
Aptinyx to Present at Cantor Fitzgerald Global Healthcare Conference
-
Aptinyx to Present at Cantor Fitzgerald Global Healthcare Conference
-
Cytokinetics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Ur-Energy Inc. Announces Closing of $10.0 Million Public Equity Offering
-
Opnet Technologies, Inc. (OPNT) Prices Offering of ~706K Shares at $17
-
Opiant Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Opiant Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Progenics Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Progenics Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
CRH Medical Corporation To Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
CytomX to Present at Upcoming Healthcare Conferences
-
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference
-
Pieris Pharmaceuticals to Present at Investor Conferences in October
-
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference
-
Eiger BioPharmaceuticals to Participate in Investor Conferences
-
Krystal Biotech to Present at Upcoming Cantor Fitzgerald and Ladenburg Thalmann Conferences
-
Knight to Present at the Cantor Fitzgerald Global Healthcare Conference in New York City
-
SCYNEXIS, Inc. to Present at Upcoming Investor Conferences
-
Melinta Therapeutics to Present at Upcoming Investor Conferences
-
Selecta Biosciences to Present at the Cantor Fitzgerald Global Healthcare Conference on October 02, 2018
-
Pieris Pharmaceuticals to Present at Investor Conferences in October
-
DURECT to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Catalyst Biosciences to Present at Two Upcoming Healthcare Investor Conferences
-
OncoSec to Present at Cantor Fitzgerald Global Healthcare Conference
-
Arrowhead Pharmaceuticals to Present at Upcoming October 2018 Conferences
-
Ziopharm Oncology to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Aerie Pharmaceuticals to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Aptose to Present at Upcoming Investor Conferences in October 2018
-
Karyopharm to Participate in Upcoming Investor Conferences
-
PellePharm to Present at Cantor Fitzgerald Global Healthcare Conference
-
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
-
Kamada to Present Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
-
Nabriva Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Karyopharm to Participate in Upcoming Investor Conferences

